Search Results - "MILLIGAN, PAUL E."

Refine Results
  1. 1

    Clinical classification schemes for predicting hemorrhage: Results from the National Registry of Atrial Fibrillation (NRAF) by Gage, Brian F., Yan, Yan, Milligan, Paul E., Waterman, Amy D., Culverhouse, Robert, Rich, Michael W., Radford, Martha J.

    Published in The American heart journal (01-03-2006)
    “…Although warfarin and other anticoagulants can prevent ischemic events, they can cause hemorrhage. Quantifying the rate of hemorrhage is crucial for…”
    Get full text
    Journal Article
  2. 2

    Genetic-based dosing in orthopedic patients beginning warfarin therapy by Millican, Eric A., Lenzini, Petra A., Milligan, Paul E., Grosso, Leonard, Eby, Charles, Deych, Elena, Grice, Gloria, Clohisy, John C., Barrack, Robert L., Burnett, R. Stephen J., Voora, Deepak, Gatchel, Susan, Tiemeier, Amy, Gage, Brian F.

    Published in Blood (01-09-2007)
    “…High variability in drug response and a narrow therapeutic index complicate warfarin therapy initiation. No existing algorithm provides recommendations on…”
    Get full text
    Journal Article
  3. 3

    Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarin by Gage, Brian F, Eby, Charles, Milligan, Paul E, Banet, Gerald A, Duncan, Jill R, McLeod, Howard L

    Published in Thrombosis and haemostasis (01-01-2004)
    “…Knowledge of pharmacogenetics may help clinicians predict their patients' therapeutic dose of warfarin, thereby decreasing the risk of bleeding during warfarin…”
    Get more information
    Journal Article
  4. 4

    Prospective dosing of warfarin based on cytochrome P-450 2C9 genotype by Voora, Deepak, Eby, Charles, Linder, Mark W, Milligan, Paul E, Bukaveckas, Bonny L, McLeod, Howard L, Maloney, William, Clohisy, John, Burnett, R Steven, Grosso, Leonard, Gatchel, Susan K, Gage, Brian F

    Published in Thrombosis and haemostasis (01-04-2005)
    “…Cytochrome P-450 2C9 (CYP2C9) polymorphisms (CYP2C9*2 and CYP2C9*3) reduce the clearance of warfarin, increase the risk of bleeding, and prolong the time to…”
    Get more information
    Journal Article
  5. 5

    Efficacy and safety of high-dose thromboprophylaxis in morbidly obese inpatients by Wang, Tzu-Fei, Milligan, Paul E, Wong, Catherine A, Deal, Eli N, Thoelke, Mark S, Gage, Brian F

    Published in Thrombosis and haemostasis (01-01-2014)
    “…Obesity increases the risk for venous thromboembolism (VTE), but whether high-dose thromboprophylaxis is safe and effective in morbidly obese inpatients is…”
    Get more information
    Journal Article
  6. 6

    Effect of warfarin nonadherence on control of the International Normalized Ratio by Waterman, AD, Milligan, PE, Bayer, L, Banet, GA, Gatchel, SK, Gage, BF

    Published in American journal of health-system pharmacy (15-06-2004)
    “…The frequency and causes of ab- errant International Normalized Ratios (INRs) in warfarin recipients and the percentage explainable by warfarin nonadherence…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Maximal dose-response of vitamin-K2 (menaquinone-4) on undercarboxylated osteocalcin in women with osteoporosis by K Giri, Tusar, Newton, David, Chaudhary, Opal, Deych, Elena, Napoli, Nicola, Villareal, Reina, Diemer, Kathy, E Milligan, Paul, F Gage, Brian

    “…Low concentrations of serum vitamin K accompany high concentrations of undercarboxylated osteocalcin (ucOC) and osteoporotic fractures. Although vitamin K2…”
    Get full text
    Journal Article
  9. 9

    Warfarin dose reduction vs watchful waiting for mild elevations in the international normalized ratio by Banet, Gerald A, Waterman, Amy D, Milligan, Paul E, Gatchel, Susan K, Gage, Brian F

    Published in Chest (01-02-2003)
    “…Whether clinicians should decrease the warfarin dose in response to a mild, asymptomatic elevation in the international normalized ratio (INR) is unknown. The…”
    Get more information
    Journal Article
  10. 10

    Risk factors for inpatient venous thromboembolism despite thromboprophylaxis by Wang, Tzu-Fei, Wong, Catherine A, Milligan, Paul E, Thoelke, Mark S, Woeltje, Keith F, Gage, Brian F

    Published in Thrombosis research (01-01-2014)
    “…Abstract Introduction Venous thromboembolism (VTE) is the most common preventable cause of morbidity and mortality in the hospital. Adequate thromboprophylaxis…”
    Get full text
    Journal Article
  11. 11

    Multifaceted approach to reducing occurrence of severe hypoglycemia in a large healthcare system by Milligan, Paul E, Bocox, Mary C, Pratt, Elizabeth, Hoehner, Christine M, Krettek, John E, Dunagan, Wm Claiborne

    Published in American journal of health-system pharmacy (01-10-2015)
    “…PURPOSE.Substantial reductions in inpatient episodes of severe hypoglycemia achieved by a large healthcare system through enhanced use of technology and…”
    Get full text
    Journal Article
  12. 12

    Optimal Initial Dose Adjustment of Warfarin in Orthopedic Patients by Lenzini, Petra A, Grice, Gloria R, Milligan, Paul E, Gatchel, Susan K, Deych, Elena, Eby, Charles S, Burnett, R Stephen J, Clohisy, John C, Barrack, Robert L, Gage, Brian F

    Published in The Annals of pharmacotherapy (01-11-2007)
    “…Warfarin sodium is commonly prescribed for the prophylaxis and treatment of venous thromboembolism. Dosing algorithms have not been widely adopted because they…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Reducing medication prescribing errors in a teaching hospital by Garbutt, Jane, Milligan, Paul E, McNaughton, Candace, Highstein, Gabrielle, Waterman, Brian M, Dunagan, W Claiborne, Fraser, Victoria J

    “…Medication errors occur frequently, result in significant morbidity and mortality, and are often preventable. A multifaceted intervention was conducted to…”
    Get more information
    Journal Article
  15. 15

    Patient and Physician Satisfaction with a Telephone‐based Anticoagulation Service by Waterman, Amy D., Banet, Gerald, Milligan, Paul E., Frazier, Andrea, Verzino, Ellen, Walton, Brian, Gage, Brian F.

    “…OBJECTIVES: To compare the satisfaction and knowledge of patients who have their warfarin managed by their physician or by a multidisciplinary, telephone‐based…”
    Get full text
    Journal Article
  16. 16

    Substitution of Generic Warfarin for Coumadin in an HMO Setting by Milligan, Paul E, Banet, Gerald A, Waterman, Amy D, Gatchel, Susan K, Gage, Brian F

    Published in The Annals of pharmacotherapy (01-05-2002)
    “…BACKGROUND: Substitution of generic warfarin for Coumadin presents safety concerns due to warfarin's narrow therapeutic index and because a prior generic…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Pharmacogenetic dose adjustments in orthopedic patients beginning warfarin therapy by Jacobsen-Lenzini, Petra A., Eby, Charles S., Milligan, Paul E., Grice, Gloria R., Deych, Elena, Grosso, Leonard, Millican, Eric, Gatchel, Susan K., Clohisy, John C., Barrack, Robert L., Gage, Brian F.

    Published in Journal of thrombosis and thrombolysis (01-02-2008)
    “…Issue Title: Special issue on Proceedings of the 9th National Conference on Anticoagulant Therapy. Sponsored by the Anticoagulation Forum…”
    Get full text
    Journal Article
  19. 19

    Risk factors for bleeding in patients taking coumarins by Beyth, Rebecca J, Milligan, Paul E, Gage, Brian F

    Published in Current hematology reports (01-09-2002)
    “…Coumarins (e.g., warfarin) are used for the treatment and prophylaxis of venous and arterial thromboembolism. Unfortunately, their use is limited by bleeding…”
    Get more information
    Journal Article
  20. 20

    A Practical Approach to Measure the Quality of Handwritten Medication Orders: A Tool for Improvement by Garbutt, Jane, Milligan, Paul E., McNaughton, Candace, Waterman, Brian M., Dunagan, Claiborne, Fraser, Victoria J.

    Published in Journal of patient safety (01-12-2005)
    “…Objective: System level solutions to reduce prescribing errors are not yet widely implemented and prescribing errors commonly occur in hand written orders. We…”
    Get full text
    Journal Article